Attached files

file filename
10-Q/A - 10-Q/A - BioRestorative Therapies, Inc.v232728_10qa.htm
XML - IDEA: XBRL DOCUMENT - BioRestorative Therapies, Inc.R1.htm
XML - IDEA: XBRL DOCUMENT - BioRestorative Therapies, Inc.R3.htm
EXCEL - IDEA: XBRL DOCUMENT - BioRestorative Therapies, Inc.Financial_Report.xls
XML - IDEA: XBRL DOCUMENT - BioRestorative Therapies, Inc.R5.htm
XML - IDEA: XBRL DOCUMENT - BioRestorative Therapies, Inc.R9.htm
XML - IDEA: XBRL DOCUMENT - BioRestorative Therapies, Inc.R2.htm
XML - IDEA: XBRL DOCUMENT - BioRestorative Therapies, Inc.R7.htm
XML - IDEA: XBRL DOCUMENT - BioRestorative Therapies, Inc.R8.htm
XML - IDEA: XBRL DOCUMENT - BioRestorative Therapies, Inc.R6.htm
XML - IDEA: XBRL DOCUMENT - BioRestorative Therapies, Inc.R15.htm
XML - IDEA: XBRL DOCUMENT - BioRestorative Therapies, Inc.R14.htm
XML - IDEA: XBRL DOCUMENT - BioRestorative Therapies, Inc.R13.htm
XML - IDEA: XBRL DOCUMENT - BioRestorative Therapies, Inc.R16.htm
XML - IDEA: XBRL DOCUMENT - BioRestorative Therapies, Inc.R12.htm
XML - IDEA: XBRL DOCUMENT - BioRestorative Therapies, Inc.R10.htm
XML - IDEA: XBRL DOCUMENT - BioRestorative Therapies, Inc.R11.htm
v2.3.0.11
Condensed Consolidated Statements of Operations (USD $)
3 Months Ended 6 Months Ended 30 Months Ended
Jun. 30, 2011
Jun. 30, 2010
Jun. 30, 2011
Jun. 30, 2010
Jun. 30, 2011
Revenues          
Operating Expenses          
Marketing and promotion 17,033 65,251 61,838 88,502 265,960
Payroll and benefits 338,344   881,775   1,637,934
Consulting expenses 239,397 33,486 435,255 184,380 1,977,704
General and administrative 443,456 79,989 676,968 238,230 1,395,786
Research and development       11,620 11,620
Total Operating Expenses 1,038,230 178,726 2,055,836 522,732 5,289,004
Loss From Operations (1,038,230) (178,726) (2,055,836) (522,732) (5,289,004)
Other Income (Expense)          
Other income   11,196   11,196 11,457
Interest expense (166,610) (29,756) (262,101) (151,122) (501,315)
Total Other Expense (166,610) (18,560) (262,101) (139,926) (489,858)
Net Loss $ (1,204,840) $ (197,286) $ (2,317,937) $ (662,658) $ (5,778,862)
Net Loss Per Share - Basic and Diluted $ 0.00 $ 0.00 $ 0.00 $ 0.00  
Weighted Average Number of Common Shares Outstanding - Basic and Diluted 569,356,834 475,392,368 558,684,710 459,643,833